# LOTEMAX

NDC: 24208-503
Generic name: loteprednol etabonate
Labeler / Manufacturer: Bausch & Lomb Incorporated
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: GEL
Routes: OPHTHALMIC
Marketing started: 20121012

FDA application: NDA202872

## Active ingredients

- LOTEPREDNOL ETABONATE: 5 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"24208-503"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=24208-503
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9a666065-d467-42b8-8ecd-0ec1de9986d5